HIV-1 TAT (48-60) epitomizes a peptide evolving from the riveting transactivator of transcription (TAT) protein within the HIV-1 realm, ceaselessly propelling viral gene expression and disease progression. Its intricate peptide sequence has been subject to relentless scrutiny, envisioning a plausible gateway towards therapeutic interventions combating the pernicious HIV/AIDS. Its exceptional targeting competencies towards pivotal interplays fundamental to viral replication lay the groundwork for pioneering antiretroviral drug development.
CAT No: GR2156
CAS No:220408-24-2
Synonyms/Alias:HIV-1 TAT (48-60);220408-24-2;G13949;
1. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes
2. Implications of ligand-receptor binding kinetics on GLP-1R signalling
4. Urinary Metabolites Associated with Blood Pressure on a Low-or High-Sodium Die
5. Store-operated Ca2+ entry sustains the fertilization Ca2+ signal in pig eggs
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.